ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

644
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
bullish•Kolon TissueGene
•21 Sep 2017 19:58

TissueGene IPO Part 1 - IPO Prospectus Summary

What is Korea's hottest stock now? I guess many investors will have SillaJen, Inc. (0908477D KS) in their mind when asked this question. SillaJen's...

Logo
819 Views
Share
bullish•NCSOFT Corp
•17 Sep 2017 20:38

NCsoft Valuation Study - Lineage M Isn't a RPG, Rather a Digital Currency to Mine

NCsoft Corp (036570 KS) is one of the five stocks that have consistently ranked top in Naver Finance's most searched stock list in the past three...

Logo
533 Views
Share
bearish•Samsung Biologics
•13 Sep 2017 22:59

Biosimilar Battlefield: Samsung Bioepis Forecast

This Insight uses the biosimilar market model discussed in Surveying The Biosimilar Battlefield to build a long-term revenue forecast for the...

Share
bearish•Celltrion Healthcare
•08 Sep 2017 10:35

Surveying The Biosimilar Battlefield

The biosimilar market has been of particular interest to us in light of the high expectations set for Samsung Biologics Co., Ltd (207940 KS)  and...

Share
bearish•Celltrion Inc
•07 Sep 2017 10:09

Celltrion Has Potential Manufacturing Headaches

A Form 483 from the USFDA (attached) that criticizes aspects of Celltrion Inc (068270 KS)'s manufacturing facility in Incheon has surfaced in the...

Share
x